Overview
Neuhauser Eichner Opitz syndrome, also referred to as Neuhauser megalocornea-mental retardation (MMR) syndrome, is characterized by megalocornea, intellectual disability, and other developmental abnormalities. This report highlights associations with primary hypothyroidism and osteopenia in affected individuals 1.Diagnosis
Key Manifestations: Megalocornea, intellectual disability, and additional developmental anomalies 1.
Recommended Tests: Thyroid function tests to screen for primary hypothyroidism 1.
Bone Health Assessment: Dual-energy X-ray absorptiometry (DXA) scans to evaluate osteopenia 1.Management
Primary Hypothyroidism: Levothyroxine replacement therapy tailored to maintain normal TSH levels 1.
Osteopenia: Calcium and vitamin D supplementation to support bone health 1.
Intellectual Disability Support: Early intervention programs including physical, occupational, and speech therapy 1.Special Populations
Comorbidities: Monitor and manage concurrent primary hypothyroidism and osteopenia in affected individuals 1.Key Recommendations
Screen for primary hypothyroidism with thyroid function tests in patients diagnosed with Neuhauser MMR syndrome (Evidence: Moderate 1).
Evaluate bone mineral density using DXA scans to identify and manage osteopenia (Evidence: Moderate 1).
Initiate levothyroxine therapy for confirmed hypothyroidism, adjusting doses to normalize TSH levels (Evidence: Moderate 1).References
1 Sarkozy A, Mingarelli R, Brancati F, Dallapiccola B. Primary hypothyroidism and osteopenia associated with Neuhauser syndrome. American journal of medical genetics 2002. link